0:00
19:41
In the latest episode of the podcast Dominic Tyer speaks with GlaxoSmithKline’s Philip Cruz about the discovery and commercialisation of new vaccines in the light of the pandemic.
More episodes from "pharmaphorum Podcast"
BMS’ Catherine Owen on pharma commercialisation: the pharmaphorum podcast
25:54
Episode 42 of the pharmaphorum podcast heard from Catherine Owen, who’s senior vice president of major markets at Bristol Myers Squibb, about the future of pharma commercialisation and communications.Novartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcast
24:34
Episode 41 of the pharmaphorum podcast heard from Amit Nastik about the impact of COVID-19 on pharma supply chains and how he and his team mitigated disruption to Novartis’ own operations.Don't miss an episode of “pharmaphorum Podcast” and subscribe to it in the GetPodcast app.
Virtual engagement and collaborations: the pharmaphorum podcast
28:05
As the world passes the year and a half mark of the COVID-19 pandemic, the evolving experience of the ‘new normal’ environment across the healthcare sector has brought huge changes to the way pharma engages healthcare professionals.Biotech Insight podcast: Overcoming planning challenges in oncology
13:52
The first episode of Kantar Health’s new Biotech Insight podcast takes aim at the planning and forecasting challenges that biotechnology companies face, with a particular focus on oncology.Vertex senior country manager Nicola Massey: the pharmaphorum podcast
23:06
In the latest episode of the podcast Dominic Tyer speaks with Nicola Massey, who’s Vertex’s senior country manager in the UK and Ireland.Regenerative medicine and COVID: the pharmaphorum podcast
14:47
In the latest episode of the podcast Dominic Tyer speaks with Dr Maria Ines ‘Mari’ Mitrani, chief science officer at the clinical-stage biopharmaceutical company Organicell Regenerative Medicine.Pharmacy and clinical research: the pharmaphorum podcast
35:49
In the latest episode of the pharmaphorum podcast, pharmaphorum’s web editor Catherine Longworth speaks to Gerald Finken, the founder and CEO of RxE2. The US-based company was founded in 2019 and is on a mission to bring the practice of pharmacy into clinical research.Pharma’s post-COVID prospects: the pharmaphorum podcast
14:11
In this latest podcast, pharmaphorum spoke to Andrew Meade, life sciences lead UK and Ireland at Accenture, about the trends that emerged in this year’s Q1 results season.Galapagos UK’s Michael Smyth on COVID and RNA-based tech: the pharmaphorum podcast
17:01
Episode 35 of the pharmaphorum podcast heard from Michael Smyth about Galapagos UK and joining the company as medical director just as COVID-19 hit.Big data and cell therapy development: the pharmaphorum podcast
1:01:34
In the latest episode of the podcast pharmaphorum’s website editor Catherine Longworth speaks with Dr. Darrin Disley, CEO of UK biotech Mogrify
Get the whole world of podcasts with the free GetPodcast app.
Subscribe to your favorite podcasts, listen to episodes offline and get thrilling recommendations.
© radio.de GmbH 2021